Halladay Benjamin sold ESPR
April 17, 2025 · Form 4 insider transaction
Halladay Benjamin sold 8 shares of Esperion Therapeutics, Inc. Common Stock at $0.96 per share, a transaction worth $7.71. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
8
Price
$0.96
Total value
$7.71
InsiderHalladay Benjamin
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 17, 2025
Filing dateApril 21, 2025
Shares owned after481,702
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were sold to satisfy tax obligation on vested shares of restricted stock units.